BOSTON, May 28, 2025 -- Aktis Oncology, Inc., an oncology company focused on unlocking the breakthrough potential of targeted radiopharmaceuticals for patient populations not addressed by existing platform technologies, today announced...
Reactive Bioscience is using the world’s leading boron-based discovery platform to discover and develop medicines in innovative and imaginative new ways.
Website
© 2025 Pappas Capital, LLC. ALL RIGHTS RESERVED.